|
CN112159398A
|
|
Preparation method of paroxetine hydrochloride
|
|
CN111956779A
|
|
Preparation method of perindopril tert-butylamine salt composition
|
|
CN111747926A
|
|
Improved method for synthesis process of free hydroxypiperone alkali
|
|
CN111747862A
|
|
Method for recovering pregabalin intermediate 3-isobutyl glutaric acid monoamide
|
|
CN111732627A
|
|
Synthesis method of lisinopril impurity J
|
|
CN111635325A
|
|
Method for preparing metoprolol succinate
|
|
CN111812227A
|
|
Method for analyzing benserazide impurity A in poly-barserazide compound preparation
|
|
CN111494331A
|
|
Lacosamide medicine oral preparation and preparation method thereof
|
|
CN110793730A
|
|
Method for analyzing package integrity of injection by color water method
|
|
CN110794140A
|
|
Method for detecting bacterial endotoxin of insoluble injection
|
|
CN110702830A
|
|
High performance liquid chromatography detection method for isomer in irinotecan hydrochloride injection
|
|
CN110790755A
|
|
Improved preparation method of canagliflozin peroxide
|
|
CN110632319A
|
|
Method for detecting bacterial endotoxin in glacial acetic acid
|
|
CN110487931A
|
|
The analysis method of one kind (E) -4- phenyl -4- oxo -2- butenoic acid ethyl
|
|
WO2021022516A1
|
|
Valsartan refinement method
|
|
WO2020252662A1
|
|
Method for refining valsartan compound
|
|
CN110256264A
|
|
A kind of synthetic method of Memantine glycine
|
|
CN109928932A
|
|
A kind of Telmisartan methylene dimer and preparation method thereof
|
|
CN109942453A
|
|
A kind of new impurity and synthetic method of Valsartan
|
|
CN110003074A
|
|
A kind of preparation method of levetiracetam intermediate
|
